Impaired neonatal cardiorespiratory responses to hypoxia in mice lacking PAC1 or VPAC2 receptors

Am J Physiol Regul Integr Comp Physiol. 2019 May 1;316(5):R594-R606. doi: 10.1152/ajpregu.00250.2018. Epub 2019 Feb 13.

Abstract

The stress peptide pituitary adenylate cyclase activating polypeptide (PACAP) and its specific receptor PACAP type 1 receptor (PAC1) have been implicated in sudden infant death syndrome (SIDS). PACAP is also critical to the neonatal cardiorespiratory response to homeostatic stressors identified in SIDS, including hypoxia. However, which of PACAP's three receptors, PAC1, vasoactive intestinal peptide receptor type 1 (VPAC1), and/or vasoactive intestinal peptide receptor type 2 (VPAC2), are involved is unknown. In this study, we hypothesized that PAC1, but not VPAC2, is involved in mediating the cardiorespiratory response to hypoxia during neonatal development. To test this hypothesis, head-out plethysmography and surface ECG electrodes were used to assess the cardiorespiratory variables of unanesthetized postnatal day 4 PAC1 and VPAC2-knockout (KO) and wild-type (WT) mice in response to a 10% hypoxic challenge. Our results demonstrate that compared with WT pups, the early and late hypoxic rate of expired CO2 (V̇co2), V̇co2 and ventilatory responses were blunted in PAC1-KO neonates, and during the posthypoxic period, minute ventilation (V̇e), V̇co2 and heart rate were increased, while the increase in apneas normally associated with the posthypoxic period was reduced. Consistent with impaired cardiorespiratory control in these animals, the V̇e/V̇co2 slope was reduced in PAC1-KO pups, suggesting that breathing was inappropriately matched to metabolism. In contrast, VPAC2-KO pups exhibited elevated heart rate variability during hypoxia compared with WT littermates, but the effects of the VPAC2-KO genotype on breathing were minimal. These findings suggest that PAC1 plays the principal role in mediating the cardiorespiratory effects of PACAP in response to hypoxic stress during neonatal development and that defective PACAP signaling via PAC1 may contribute to the pathogenesis of SIDS.

Keywords: PACAP type 1 receptor; heart rate variability; neonatal development; neonatal stress response; vasoactive intestinal peptide receptor type 2; ventilation.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Newborn
  • Cardiovascular System / metabolism*
  • Cardiovascular System / physiopathology
  • Disease Models, Animal
  • Female
  • Heart Rate*
  • Humans
  • Hypoxia / genetics
  • Hypoxia / metabolism*
  • Hypoxia / physiopathology
  • Infant, Newborn
  • Lung / metabolism*
  • Lung / physiopathology
  • Male
  • Mice, Knockout
  • Pituitary Adenylate Cyclase-Activating Polypeptide / metabolism*
  • Pulmonary Ventilation*
  • Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I / deficiency*
  • Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I / genetics
  • Receptors, Vasoactive Intestinal Peptide, Type II / deficiency*
  • Receptors, Vasoactive Intestinal Peptide, Type II / genetics
  • Signal Transduction
  • Sudden Infant Death / etiology*
  • Sudden Infant Death / genetics

Substances

  • Adcyap1 protein, mouse
  • Adcyap1r1 protein, mouse
  • Pituitary Adenylate Cyclase-Activating Polypeptide
  • Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I
  • Receptors, Vasoactive Intestinal Peptide, Type II

Grants and funding